106 related articles for article (PubMed ID: 3169098)
1. Cardiotoxicity of mitozantrone assessed by stress and resting nuclear ventriculography.
Cassidy J; Merrick MV; Smyth JF; Leonard RC
Eur J Cancer Clin Oncol; 1988 May; 24(5):935-8. PubMed ID: 3169098
[TBL] [Abstract][Full Text] [Related]
2. Myocyte cell damage after administration of doxorubicin or mitoxantrone in breast cancer patients assessed by indium 111 antimyosin monoclonal antibody studies.
Estorch M; Carrió I; Martínez-Duncker D; Berná L; Torres G; Alonso C; Ojeda B
J Clin Oncol; 1993 Jul; 11(7):1264-8. PubMed ID: 8315423
[TBL] [Abstract][Full Text] [Related]
3. Mitoxantrone versus doxorubicin in combination chemotherapy for advanced carcinoma of the breast.
Leonard RC; Cornbleet MA; Kaye SB; Soukop M; White G; Hutcheon AW; Robinson S; Kerr ME; Smyth JF
J Clin Oncol; 1987 Jul; 5(7):1056-63. PubMed ID: 3298559
[TBL] [Abstract][Full Text] [Related]
4. Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast.
Speyer JL; Green MD; Dubin N; Blum RH; Wernz JC; Roses D; Sanger J; Muggia FM
Am J Med; 1985 Apr; 78(4):555-63. PubMed ID: 3838618
[TBL] [Abstract][Full Text] [Related]
5. Primary chemotherapy with mitoxantrone and prednisone in advanced breast carcinoma. A phase II study.
Carmo-Pereira J; Costa FO; Henriques E; Cantinho-Lopes MG; Godinho F; Sales-Luis A
Eur J Cancer Clin Oncol; 1988 Mar; 24(3):473-6. PubMed ID: 3383949
[TBL] [Abstract][Full Text] [Related]
6. A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer.
Jain KK; Casper ES; Geller NL; Hakes TB; Kaufman RJ; Currie V; Schwartz W; Cassidy C; Petroni GR; Young CW
J Clin Oncol; 1985 Jun; 3(6):818-26. PubMed ID: 3859587
[TBL] [Abstract][Full Text] [Related]
7. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
[TBL] [Abstract][Full Text] [Related]
8. Ventricular late potentials in the assessment of mitoxantrone cardiotoxicity.
de Leonardis V; Bartalucci S; Cinelli P; De Scalzi M; Becucci A; Lottini G; Neri B
Cardiology; 1991; 79(2):110-5. PubMed ID: 1933962
[TBL] [Abstract][Full Text] [Related]
9. Combined mitoxantrone plus doxorubicin in the treatment of breast cancer.
Stewart DJ; Perrault DJ; Maroun JA; Lefebvre BM
Am J Clin Oncol; 1987 Aug; 10(4):335-40. PubMed ID: 3618544
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity evaluation in patients treated with a mitoxantrone combination as adjuvant chemotherapy for breast cancer.
Fountzilas G; Afthonidis D; Geleris P; Salem N; Kottas G; Halkidis C; Apostolidis P; Beer M; Tourkantonis A
Anticancer Res; 1992; 12(1):231-4. PubMed ID: 1567171
[TBL] [Abstract][Full Text] [Related]
11. Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Avilés A; Arévila N; Díaz Maqueo JC; Gómez T; García R; Nambo MJ
Leuk Lymphoma; 1993 Oct; 11(3-4):275-9. PubMed ID: 8260898
[TBL] [Abstract][Full Text] [Related]
12. Comparison of mitozantrone and epirubicin in advanced breast cancer.
Cook AM; Chambers EJ; Rees GJ
Clin Oncol (R Coll Radiol); 1996; 8(6):363-6. PubMed ID: 8973851
[TBL] [Abstract][Full Text] [Related]
13. Multicenter randomized controlled clinical trial to evaluate cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer.
Venturini M; Michelotti A; Del Mastro L; Gallo L; Carnino F; Garrone O; Tibaldi C; Molea N; Bellina RC; Pronzato P; Cyrus P; Vinke J; Testore F; Guelfi M; Lionetto R; Bruzzi P; Conte PF; Rosso R
J Clin Oncol; 1996 Dec; 14(12):3112-20. PubMed ID: 8955656
[TBL] [Abstract][Full Text] [Related]
14. A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer.
Jodrell DI; Smith IE; Mansi JL; Pearson MC; Walsh G; Ashley S; Sinnett HD; McKinna JA
Br J Cancer; 1991 May; 63(5):794-8. PubMed ID: 2039705
[TBL] [Abstract][Full Text] [Related]
15. Mitoxantrone in advanced breast cancer--a phase II study with special attention to cardiotoxicity.
Coleman RE; Maisey MN; Knight RK; Rubens RD
Eur J Cancer Clin Oncol; 1984 Jun; 20(6):771-6. PubMed ID: 6540179
[TBL] [Abstract][Full Text] [Related]
16. Clinical effects of combination therapy with mitoxantrone, vincristine, and prednisolone in breast cancer.
Katsumata K; Tomioka H; Kusama M; Aoki T; Koyanagi Y
Cancer Chemother Pharmacol; 2003 Jul; 52(1):86-8. PubMed ID: 12764670
[TBL] [Abstract][Full Text] [Related]
17. Interstitial pneumonitis following mitozantrone, chlorambucil and prednisolone (MCP) chemotherapy.
Tomlinson J; Tighe M; Johnson S; Stone R; Nicholson AG; Rule S
Clin Oncol (R Coll Radiol); 1999; 11(3):184-6. PubMed ID: 10465473
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of combination chemotherapy with mitoxantrone, vincristine, prednisolone (MVP) for recurrence of breast cancer].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Momose F
Gan To Kagaku Ryoho; 1995 Jan; 22(1):83-6. PubMed ID: 7826082
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of ventricular function by echocardiography and radionuclide angiography in patients treated with mitoxantrone.
Villani F; Galimberti M; Crippa F
Drugs Exp Clin Res; 1989; 15(10):501-6. PubMed ID: 2632218
[TBL] [Abstract][Full Text] [Related]
20. Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.
Fei HW; Ali MT; Tan TC; Cheng KH; Salama L; Hua L; Zeng X; Halpern EF; Taghian A; MacDonald SM; Scherrer-Crosbie M
Echocardiography; 2016 Apr; 33(4):519-26. PubMed ID: 26992012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
